Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01405105 · ClinicalTrials.gov registry record
Exacerbating Factors in Inflammatory Bowel Disease
A clinical trial, sponsored by Dallas VA Medical Center.
- Completed
- Registry status
- 134
- Enrollment target
NCT01405105: Completed study, sponsored by Dallas VA Medical Center.
NCT01405105 is a clinical trial that has completed, run by Dallas VA Medical Center. The registered enrollment target is 134 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01405105 has completed, sponsored by Dallas VA Medical Center.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
Cross-sectional study of potential triggers for flares of Crohn's disease or ulcerative colitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-06 |
What the finished NCT01405105 record still lists
NCT01405105 is an observational study that tracks outcomes without assigning an intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01405105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01405105 about?
NCT01405105 is a clinical study titled "Exacerbating Factors in Inflammatory Bowel Disease". Cross-sectional study of potential triggers for flares of Crohn's disease or ulcerative colitis.
What is the current status of trial NCT01405105?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2009-08. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT01405105?
This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia